Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis.

In patients undergoing complex or noncomplex PCI, there was no significant difference between treatment groups, however, both subgroups showed a trend toward a reduction of major bleeding in the short‐term DAPT followed by ticagrelor monotherapy group (RR 0.62, 95% CI, 0.30–1.30, P = 0.21, I 2 = 72%; Figure 3d and RR 0.74, 95% CI, 0.48–1.14, P = 0.17, I 2 = 54%, respectively; Figure 3d ).

also in 53,322 other papers